Northern Trust Corp Haemonetics Corp Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Haemonetics Corp stock. As of the latest transaction made, Northern Trust Corp holds 584,413 shares of HAE stock, worth $49.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

584,413

Previous 585,706 0.22%

Holding current value

$49.6 Million

Previous $48.5 Million 3.07%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $93,677 - $118,412	-1,293 Reduced 0.22%	584,413 $47 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $836,447 - $1 Million	10,296 Added 1.79%	585,706 $48.5 Million
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $3.78 Million - $4.53 Million	-53,102 Reduced 8.45%	575,410 $49.1 Million
Q4 2023 Feb 13, 2024	SELL	$80.59 - $92.61 $898,739 - $1.03 Million	-11,152 Reduced 1.74%	628,512 $53.7 Million
Q3 2023 Nov 13, 2023	SELL	$82.56 - $93.49 $782,173 - $885,724	-9,474 Reduced 1.46%	639,664 $57.3 Million
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $55,860 - $61,809	691 Added 0.11%	649,138 $55.3 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $172,199 - $214,450	2,367 Added 0.37%	648,447 $53.7 Million
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $337,937 - $394,176	-4,576 Reduced 0.7%	646,080 $50.8 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $729,469 - $906,477	-11,524 Reduced 1.74%	650,656 $48.2 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $798,272 - $1.07 Million	-16,202 Reduced 2.39%	662,180 $43.2 Million
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $1.26 Million - $1.81 Million	-28,674 Reduced 4.06%	678,382 $42.9 Million
Q4 2021 Feb 08, 2022	SELL	$49.55 - $74.59 $309,687 - $466,187	-6,250 Reduced 0.88%	707,056 $37.5 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $44,582 - $54,636	774 Added 0.11%	713,306 $50.4 Million
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $14.2 Million - $32.5 Million	274,322 Added 62.6%	712,532 $47.5 Million
Q1 2021 May 12, 2021	BUY	$111.01 - $139.48 $3.5 Million - $4.4 Million	31,518 Added 7.75%	438,210 $48.6 Million
Q4 2020 Feb 11, 2021	SELL	$88.75 - $119.95 $280,361 - $378,922	-3,159 Reduced 0.77%	406,692 $48.3 Million
Q3 2020 Nov 16, 2020	SELL	$75.65 - $93.58 $1.05 Million - $1.3 Million	-13,895 Reduced 3.28%	409,851 $35.8 Million
Q2 2020 Aug 14, 2020	SELL	$84.96 - $118.91 $34.1 Million - $47.7 Million	-401,532 Reduced 48.65%	423,746 $38 Million
Q1 2020 May 14, 2020	SELL	$74.34 - $121.82 $98,277 - $161,046	-1,322 Reduced 0.16%	825,278 $82.2 Million
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $1.83 Million - $2.07 Million	-16,011 Reduced 1.9%	826,600 $95 Million
Q3 2019 Nov 13, 2019	BUY	$117.16 - $138.52 $822,931 - $972,964	7,024 Added 0.84%	842,611 $106 Million
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $364,396 - $536,475	4,458 Added 0.54%	835,587 $101 Million
Q1 2019 May 13, 2019	BUY	$83.25 - $102.12 $312,437 - $383,256	3,753 Added 0.45%	831,129 $72.7 Million
Q4 2018 Feb 12, 2019	SELL	$90.66 - $116.63 $894,451 - $1.15 Million	-9,866 Reduced 1.18%	827,376 $82.8 Million
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $205,378 - $261,586	-2,283 Reduced 0.27%	837,242 $95.9 Million
Q2 2018 Sep 18, 2018	SELL	$71.53 - $95.75 $284,403 - $380,702	-3,976 Reduced 0.47%	839,525 $75.3 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $11.4 Million - $15.3 Million	159,430 Added 23.31%	843,501 $75.6 Million
Q1 2018 May 09, 2018	BUY	$60.72 - $74.41 $447,627 - $548,550	7,372 Added 1.09%	684,071 $50 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $250,472 - $328,633	-5,571 Reduced 0.82%	676,699 $39.3 Million
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $27.6 Million - $30.6 Million	682,270	682,270 $30.6 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Haemonetics Corp Transaction History